225 related articles for article (PubMed ID: 30383650)
1. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
[TBL] [Abstract][Full Text] [Related]
2. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
[TBL] [Abstract][Full Text] [Related]
3. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
Mitaka C; Kawagoe I; Satoh D; Hayashida M
Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680
[TBL] [Abstract][Full Text] [Related]
4. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
Yokoyama H; Takahashi N; Katsuoka Y; Inomata M; Ito T; Meguro K; Kameoka Y; Tsumanuma R; Murai K; Noji H; Ishizawa K; Ito S; Onishi Y; Harigae H;
Int J Hematol; 2017 May; 105(5):606-613. PubMed ID: 28176226
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
[TBL] [Abstract][Full Text] [Related]
8. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
[TBL] [Abstract][Full Text] [Related]
10. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
Aota T; Wada H; Yamashita Y; Matsumoto T; Ohishi K; Suzuki K; Imai H; Usui M; Isaji S; Katayama N
Int J Hematol; 2016 Feb; 103(2):173-9. PubMed ID: 26590919
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A
Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
Ikezoe T
Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.
Ito T; Nagahara A; Osada T; Kato J; Ueyama H; Saito H; Taniki N; Kanazawa R; Shimizu R; Sai J; Shiina S; Watanabe S
Biomed Rep; 2015 Jul; 3(4):457-460. PubMed ID: 26171148
[TBL] [Abstract][Full Text] [Related]
17. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience.
Yagasaki H; Kato M; Shimozawa K; Hirai M; Nishikawa E; Okuma H; Ishii W; Imai Y; Matsumura M; Yonezawa R; Yoshikawa K; Shichino H; Chin M; Mugishima H
Thromb Res; 2012 Dec; 130(6):e289-93. PubMed ID: 23123162
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
[TBL] [Abstract][Full Text] [Related]
19. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
[TBL] [Abstract][Full Text] [Related]
20. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]